DCPH - Deciphera Pharmaceuticals, Inc.
IEX Last Trade
12.94
0.120 0.927%
Share volume: 346,158
Last Updated: Tue 08 Aug 2023 09:59:58 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.25%
PREVIOUS CLOSE
CHG
CHG%
$12.82
0.12
0.94%
View ratios
| Fiscal Date | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | |
| Report Date | 2022-05-04 | 2022-08-04 | 2022-11-03 | 2023-02-07 | 2023-05-03 | 2023-08-09 | 2023-10-30 | |
| Cash flow financing | 83.000 K | 164.224 M | 209.000 K | 478.000 K | 134.686 M | 838.000 K | 15.590 M | |
| Other financing cash flows | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cash flow | -51.352 M | -45.524 M | -20.828 M | -35.158 M | -49.455 M | -38.626 M | -29.807 M | |
| Net income | -46.892 M | -43.061 M | -43.043 M | -45.935 M | -49.609 M | -48.562 M | -49.581 M | |
| Depreciation | 783.000 K | 820.000 K | 742.000 K | 601.000 K | 608.000 K | 571.000 K | 465.000 K | |
| Changes in inventories | 19.627 M | 20.889 M | 19.129 M | 20.561 M | 25.528 M | 25.343 M | 27.105 M | |
| Changes in receivables | 23.151 M | 25.851 M | 23.278 M | 22.429 M | 22.439 M | 23.200 M | 27.549 M | |
| Investing Cashflow | 59.652 M | -104.194 M | -6.071 M | 16.304 M | -35.414 M | 4.361 M | 41.403 M | |
| Net Borrowings | -246.897 M | -371.208 M | -348.594 M | -320.854 M | -399.869 M | -328.985 M | -336.214 M | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 0.000 | -287.000 K | -573.000 K | 19.000 K | -360.000 K | -293.000 K | -62.000 K | |
| Cash Change | 256.553 M | 383.847 M | 364.577 M | 324.486 M | 398.633 M | 328.740 M | 339.075 M |